Invesaro

Stocks Consumer discretionary CL

NYSE · Consumer discretionary

Colgate Palmolive Co (CL)

Colgate Palmolive Co brought in $21B of revenue over the twelve months to June 30, 2026, up 5.2% from a year earlier. Net income was $2B, a net margin of 9.7%. Operating cash flow minus capital spending left $3.6B of free cash flow in fiscal 2025. At June 30, 2026 it held $1.4B in cash against $7.8B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 31, 2026.

Price
$86.06
+0.87% on the day · September 25, 2026
52-week range $74.55 to $99.33
Market cap
$68.6B
Revenue (last 12 months)
$21B
+5.2% year on year
Net margin
9.7%
P/E
32.7
on FY2025 diluted EPS

What Colgate Palmolive Co does

Colgate-Palmolive manufactures and sells oral hygiene, personal care, home cleaning, and pet nutrition products. Its product lines include toothpaste, toothbrushes, mouthwashes, bar soaps, shower gels, deodorants, dishwashing detergents, household cleaners, and specialized pet foods distributed to retail stores, pharmacies, and veterinary clinics. Its shares trade on NYSE under the ticker CL.

Revenue and profit by year

Revenue
FY18: $15.5B $15.5B FY18FY19: $15.7B $15.7B FY19FY20: $16.5B $16.5B FY20FY21: $17.4B $17.4B FY21FY22: $18B $18B FY22FY23: $19.5B $19.5B FY23FY24: $20.1B $20.1B FY24FY25: $20.4B $20.4B FY25
Net income
FY18: $2.4B $2.4B FY18FY19: $2.4B $2.4B FY19FY20: $2.7B $2.7B FY20FY21: $2.2B $2.2B FY21FY22: $1.8B $1.8B FY22FY23: $2.3B $2.3B FY23FY24: $2.9B $2.9B FY24FY25: $2.1B $2.1B FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$20.4B$3.3B$2.1B$2.63$3.6B
2024$20.1B$4.3B$2.9B$3.51$3.5B
2023$19.5B$4B$2.3B$2.77$3B
2022$18B$2.9B$1.8B$2.13$1.9B
2021$17.4B$3.3B$2.2B$2.55$2.8B
2020$16.5B$3.9B$2.7B$3.14$3.3B

Latest SEC filings

What Colgate Palmolive Co has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. July 31, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. July 31, 2026
  3. June 24, 2026
  4. June 24, 2026
  5. June 1, 2026
  6. May 13, 2026
  7. May 1, 2026
    Quarterly report 10-Q · period to March 31, 2026
  8. May 1, 2026
  9. April 29, 2026
  10. April 16, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 18, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about CL

What does Colgate Palmolive Co do?

Colgate-Palmolive manufactures and sells oral hygiene, personal care, home cleaning, and pet nutrition products. Its product lines include toothpaste, toothbrushes, mouthwashes, bar soaps, shower gels, deodorants, dishwashing detergents, household cleaners, and specialized pet foods distributed to retail stores, pharmacies, and veterinary clinics. Its shares trade on NYSE under the ticker CL.

Is Colgate Palmolive Co profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $2B on revenue of $21B, a net margin of 9.7%.

How much revenue does Colgate Palmolive Co make?

Over the twelve months to June 30, 2026 Colgate Palmolive Co reported revenue of $21B. That is 5.2% more than a year earlier.

When did Colgate Palmolive Co last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 31, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 18, 2026.

Similar companies

Follow CL

Get an email when Colgate Palmolive Co files with the SEC: results, executive changes, material agreements and annual reports.

Follow CL: get an email when it files

Where the numbers come from

Financial figures are the values Colgate Palmolive Co tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.